https://www.selleckchem.com/pr....oducts/bay-11-7085.h
Despite randomized controlled trials (RCTs) and trial-based meta-analyses, the optimal rescue therapy for patients with acute glucorticosteroid-refractory ulcerative colitis (UC), to avoid colectomy and improve long-term outcomes, remains unclear. We conducted a network meta-analysis examining this issue. We searched MEDLINE, EMBASE, EMBASE Classic, and the Cochrane central register to June 2020. We included RCTs comparing ciclosporin and infliximab, either with each other, or with placebo, in patients with glucorticosteroid-refract
Like
Comment
Share
